Advanced
  Home Compare Reports

Comparison with Similar Reports

Allergy Diagnostics Market by Product & Service (Consumables, Instruments (Immunoassay Analyzer, ELISA Analyzer, Luminometer), Service), Allergen (Foo...

Publisher:        MarketsandMarkets

# of Pages:        288

Rating: 

1 User License $4,950

Publication Date:  August, 2021

Price:       $4,950 / User License




1 INTRODUCTION 42
1.1 OBJECTIVES OF THE STUDY 42
1.2 MARKET DEFINITION 42
1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY 43
1.3 MARKET SCOPE 44
1.3.1 MARKET SEGMENTATION 44
1.3.2 YEARS CONSIDERED FOR THE STUDY 45
1.4 CURRENCY 45
1.5 LIMITATIONS 45
1.6 MARKET STAKEHOLDERS 46
1.7 SUMMARY OF CHANGES 46
2 RESEARCH METHODOLOGY 47
2.1 RESEARCH DATA 47
FIGURE 1 RESEARCH DESIGN 47
2.1.1 SECONDARY DATA 48
2.1.1.1 Key data from secondary sources 49
2.1.2 PRIMARY DATA 49
FIGURE 2 PRIMARY SOURCES 49
2.1.2.1 Key data from primary sources 50
2.1.2.2 Key industry insights 51
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 51
2.2 MARKET SIZE ESTIMATION 52
FIGURE 4 BOTTOM-UP APPROACH 52
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 53
FIGURE 6 TOP-DOWN APPROACH 54
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 55
FIGURE 7 DATA TRIANGULATION METHODOLOGY 55
2.4 MARKET SHARE ANALYSIS 56
2.5 ASSUMPTIONS FOR THE STUDY 56
2.6 RISK ASSESSMENT/FACTOR ANALYSIS 57
TABLE 1 RISKS 57
2.7 COVID-19 ECONOMIC ASSESSMENT 57
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 57
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY 58
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 59
 
3 EXECUTIVE SUMMARY 60
FIGURE 10 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD BILLION) 60
FIGURE 11 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2021 VS. 2026 (USD BILLION) 61
FIGURE 12 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2021 VS. 2026 (USD BILLION) 62
FIGURE 13 ALLERGY DIAGNOSTICS MARKET, BY END USER,
2021 VS. 2026 (USD BILLION) 63
FIGURE 14 ALLERGY DIAGNOSTICS MARKET, BY REGION, 2021 VS. 2026 (USD BILLION) 64
4 PREMIUM INSIGHTS 65
4.1 ALLERGY DIAGNOSTICS MARKET OVERVIEW 65
FIGURE 15 THE RISING INCIDENCE AND HEAVY ECONOMIC BURDEN OF ALLERGIES IS A KEY FACTOR DRIVING THE MARKET GROWTH 65
4.2 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET SHARE, BY ALLERGEN (2020) 66
FIGURE 16 THE INHALED ALLERGEN SEGMENT DOMINATED THE MARKET IN 2020 66
4.3 GEOGRAPHICAL SNAPSHOT OF THE ALLERGY DIAGNOSTICS MARKET 67
FIGURE 17 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
5.2 MARKET DYNAMICS 68
FIGURE 18 ALLERGY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS 68
5.2.1 DRIVERS 69
5.2.1.1 The high incidence and heavy economic burden of allergic diseases 69
5.2.1.2 Rising environmental pollution levels 69
5.2.1.3 Increasing funding initiatives in allergy diagnostics 70
5.2.1.4 Growing access to health insurance 71
5.2.2 RESTRAINTS 71
5.2.2.1 Premium costs associated with allergy diagnostic instruments 71
5.2.2.2 Limited awareness and poor implementation of allergy testing methods 72
5.2.3 OPPORTUNITIES 72
5.2.3.1 Use of mHealth in allergy diagnosis 72
5.2.4 CHALLENGES 73
5.2.4.1 Shortage of allergists 73
5.2.5 TRENDS 73
5.2.5.1 Reagent rental agreements 73
5.3 SUPPLY CHAIN ANALYSIS 73
FIGURE 19 DIRECT DISTRIBUTION, THE PREFERRED STRATEGY FOR PROMINENT COMPANIES 74
 
5.4 VALUE CHAIN ANALYSIS 74
FIGURE 20 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES 75
5.5 ECOSYSTEM ANALYSIS OF THE ALLERGY DIAGNOSTICS MARKET 76
FIGURE 21 ECOSYSTEM ANALYSIS OF THE ALLERGY DIAGNOSTICS MARKET 76
5.5.1 ROLE IN THE ECOSYSTEM 76
FIGURE 22 KEY PLAYERS IN THE ALLERGY DIAGNOSTICS MARKET ECOSYSTEM 77
5.6 PRICING ANALYSIS 77
TABLE 2 AVERAGE SELLING PRICES OF ALLERGY DIAGNOSTICS PRODUCTS 77
5.7 REGULATORY OVERVIEW 78
5.7.1 US 78
TABLE 3 US: CLASSIFICATION OF IMMUNOASSAY PRODUCTS 78
FIGURE 23 US: REGULATORY PROCESS FOR IVD DEVICES 79
5.7.2 CANADA 80
FIGURE 24 CANADA: REGULATORY PROCESS FOR IVD DEVICES IN CANADA 80
5.7.3 EUROPE 81
TABLE 4 EUROPE: CLASSIFICATION OF IVD DEVICES 81
5.7.3.1 Europe: regulatory process for IVD devices 82
5.7.4 JAPAN 83
5.7.4.1 Japan: regulatory process for IVD devices 83
TABLE 5 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 84
5.7.5 CHINA 84
TABLE 6 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 84
5.7.6 INDIA 84
5.7.6.1 India: regulatory process for IVD devices 85
5.7.7 INDONESIA 85
TABLE 7 INDONESIA: REGISTRATION PROCESS FOR IVD DEVICES 86
5.7.8 RUSSIA 86
TABLE 8 RUSSIA: CLASSIFICATION OF IVD DEVICES 86
5.7.9 SAUDI ARABIA 87
TABLE 9 SAUDI ARABIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 87
5.7.10 MEXICO 87
5.7.10.1 Mexico: regulatory process for IVD devices 87
TABLE 10 MEXICO: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 88
5.7.11 BRAZIL 88
5.7.11.1 Brazil: regulatory process for IVD devices 89
5.7.12 SOUTH KOREA 89
TABLE 11 SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 89
5.8 TRADE ANALYSIS 90
5.8.1 IMPORT DATA FOR HS CODE 902750, BY COUNTRY,
2016–2020 (USD THOUSAND) 90
5.8.2 EXPORT DATA FOR HS CODE 902750, BY COUNTRY,
2017–2019 (USD THOUSAND) 91
5.8.3 EXPORT DATA FOR HS CODE 902750, BY COUNTRY, 2016–2020 91
5.8.4 IMPORT DATA FOR HS CODE 902750, BY COUNTRY, 2016–2020 92
5.9 PATENT ANALYSIS 92
5.9.1 PATENT ANALYSIS: LUMINOMETERS 92
5.10 TECHNOLOGY ANALYSIS 93
5.11 PORTER’S FIVE FORCES ANALYSIS 93
TABLE 12 HIGH CONSOLIDATION IN THE MARKET TO RESTRICT THE ENTRY OF NEW PLAYERS 93
5.11.1 DEGREE OF COMPETITION 94
5.11.2 BARGAINING POWER OF SUPPLIERS 94
5.11.3 BARGAINING POWER OF BUYERS 94
5.11.4 THREAT OF SUBSTITUTES 94
5.11.5 THREAT OF NEW ENTRANTS 94
5.12 COVID-19 IMPACT ANALYSIS FOR THE ALLERGY DIAGNOSTICS MARKET 94
5.13 RANGES/ SCENARIOS 95
5.13.1 ALLERGY DIAGNOSTICS MARKET FORECAST 95
FIGURE 25 REALISTIC SCENARIO OF THE ALLERGY DIAGNOSTICS MARKET 95
FIGURE 26 PESSIMISTIC SCENARIO OF THE ALLERGY DIAGNOSTICS MARKET 96
FIGURE 27 OPTIMISTIC SCENARIO OF THE ALLERGY DIAGNOSTICS MARKET 96
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES 97
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR ALLERGY DIAGNOSTICS MANUFACTURERS 97
FIGURE 28 REVENUE SHIFT FOR ALLERGY DIAGNOSTICS MARKET 97
6 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 98
6.1 INTRODUCTION 99
TABLE 13 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 99
TABLE 14 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 99
6.2 CONSUMABLES 100
6.2.1 CONSUMABLES ARE THE MOST WIDELY USED PRODUCTS FOR ALLERGY TESTING 100
TABLE 15 ALLERGY DIAGNOSTICS CONSUMABLES MARKET, BY REGION,
2016–2019 (USD MILLION) 101
TABLE 16 ALLERGY DIAGNOSTICS CONSUMABLES MARKET, BY REGION,
2020–2026 (USD MILLION) 101
6.3 INSTRUMENTS 101
TABLE 17 ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 102
TABLE 18 ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 102
TABLE 19 ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY REGION,
2016–2019 (USD MILLION) 103
TABLE 20 ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY REGION,
2020–2026 (USD MILLION) 103
6.3.1 IMMUNOASSAY ANALYZERS 103
6.3.1.1 Immunoassay analyzers are highly preferred for allergy diagnostics 103
TABLE 21 ALLERGY DIAGNOSTICS FOR IMMUNOASSAY ANALYZERS MARKET,
BY REGION, 2016–2019 (USD MILLION) 104
TABLE 22 ALLERGY DIAGNOSTICS FOR IMMUNOASSAY ANALYZERS MARKET,
BY REGION, 2020–2026 (USD MILLION) 104
6.3.2 ELISA ANALYZERS 105
6.3.2.1 The precision offered by ELISA tests to propel the growth of the segment 105
TABLE 23 ALLERGY DIAGNOSTICS FOR ELISA ANALYZERS MARKET, BY REGION,
2016–2019 (USD MILLION) 105
TABLE 24 ALLERGY DIAGNOSTICS FOR ELISA ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 106
6.3.3 LUMINOMETERS 106
6.3.3.1 Luminometers are convenient to use, thus leading to their increased adoption 106
TABLE 25 ALLERGY DIAGNOSTICS FOR LUMINOMETERS MARKET, BY REGION,
2016–2019 (USD MILLION) 107
TABLE 26 ALLERGY DIAGNOSTICS FOR LUMINOMETERS MARKET, BY REGION,
2020–2026 (USD MILLION) 107
6.3.4 OTHER INSTRUMENTS 107
TABLE 27 ALLERGY DIAGNOSTICS FOR OTHER INSTRUMENTS MARKET, BY REGION, 2016–2019 (USD MILLION) 108
TABLE 28 ALLERGY DIAGNOSTICS FOR OTHER INSTRUMENTS MARKET, BY REGION, 2020–2026 (USD MILLION) 108
6.4 SERVICES 109
6.4.1 RISING CASES OF ALLERGIES TO DRIVE THE GROWTH OF THE SERVICES SEGMENT 109
TABLE 29 ALLERGY DIAGNOSTICS SERVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 109
TABLE 30 ALLERGY DIAGNOSTICS SERVICES MARKET, BY REGION,
2020–2026 (USD MILLION) 109
7 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE 110
7.1 INTRODUCTION 111
TABLE 31 ALLERGY TESTS ADVANTAGES AND LIMITATIONS 111
TABLE 32 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 111
TABLE 33 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 112
7.2 IN VIVO TESTS 112
TABLE 34 IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 112
TABLE 35 IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 112
TABLE 36 IN VIVO TESTS MARKET, BY REGION, 2016–2019 (USD MILLION) 113
TABLE 37 IN VIVO TESTS MARKET, BY REGION, 2020–2026 (USD MILLION) 113
7.2.1 SKIN PRICK TESTS 113
7.2.1.1 Skin prick tests are the most widely preferred in vivo allergy tests 113
TABLE 38 SKIN PRICK TESTS MARKET, BY REGION, 2016–2019 (USD MILLION) 114
TABLE 39 SKIN PRICK TESTS MARKET, BY REGION, 2020–2026 (USD MILLION) 114
7.2.2 PATCH TESTS 115
7.2.2.1 Patch tests help in the diagnosis of contact dermatitis, unlike the skin prick test 115
TABLE 40 PATCH TESTS MARKET, BY REGION, 2016–2019 (USD MILLION) 115
TABLE 41 PATCH TESTS MARKET, BY REGION, 2020–2026 (USD MILLION) 115
7.2.3 OTHER IN VIVO TESTS 116
TABLE 42 OTHER IN VIVO TESTS MARKET, BY REGION, 2016–2019 (USD MILLION) 116
TABLE 43 OTHER IN VIVO TESTS MARKET, BY REGION, 2020–2026 (USD MILLION) 117
7.3 IN VITRO TESTS 117
7.3.1 IN VITRO ALLERGY TESTS ARE SET TO WITNESS SIGNIFICANT GROWTH DURING THE FORECAST PERIOD 117
TABLE 44 IN VITRO TESTS MARKET, BY REGION, 2016–2019 (USD MILLION) 118
TABLE 45 IN VITRO TESTS MARKET, BY REGION, 2020–2026 (USD MILLION) 118
8 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN 119
8.1 INTRODUCTION 120
TABLE 46 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016–2019 (USD MILLION) 120
TABLE 47 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020–2026 (USD MILLION) 120
8.2 INHALED ALLERGENS 121
8.2.1 INHALED ALLERGENS DOMINATED THE MARKET IN 2020 121
TABLE 48 INHALED ALLERGENS MARKET, BY REGION, 2016–2019 (USD MILLION) 121
TABLE 49 INHALED ALLERGENS MARKET, BY REGION, 2020–2026 (USD MILLION) 122
8.3 FOOD ALLERGENS 122
8.3.1 FOOD ALLERGY IS FOUND TO BE MORE PREVALENT AMONG CHILDREN 122
TABLE 50 SPECIFIC FOOD-INDUCED ALLERGIC CONDITIONS 123
TABLE 51 FOOD ALLERGENS MARKET, BY REGION, 2016–2019 (USD MILLION) 123
TABLE 52 FOOD ALLERGENS MARKET, BY REGION, 2020–2026 (USD MILLION) 124
8.4 DRUG ALLERGENS 124
8.4.1 THE DRUG ALLERGY SEGMENT IS EXPECTED TO WITNESS CONSIDERABLE GROWTH DURING THE FORECAST PERIOD 124
TABLE 53 DRUG ALLERGENS MARKET, BY REGION, 2016–2019 (USD MILLION) 125
TABLE 54 DRUG ALLERGENS MARKET, BY REGION, 2020–2026 (USD MILLION) 125
8.5 OTHER ALLERGENS 125
TABLE 55 OTHER ALLERGENS MARKET, BY REGION, 2016–2019 (USD MILLION) 126
TABLE 56 OTHER ALLERGENS MARKET, BY REGION, 2020–2026 (USD MILLION) 126
 
9 ALLERGY DIAGNOSTICS MARKET, BY END USER 127
9.1 INTRODUCTION 128
TABLE 57 ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016–2019 (USD MILLION) 128
TABLE 58 ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020–2026 (USD MILLION) 128
9.2 DIAGNOSTIC LABORATORIES 129
9.2.1 DIAGNOSTIC LABORATORIES ACCOUNTED FOR THE LARGEST SHARE OF THE END-USER MARKET IN 2020 129
TABLE 59 ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES,
BY REGION, 2016–2019 (USD MILLION) 129
TABLE 60 ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES,
BY REGION, 2020–2026 (USD MILLION) 130
9.3 HOSPITAL-BASED LABORATORIES 130
9.3.1 HOSPITAL-BASED LABORATORIES ARE MORE ACCESSIBLE TO PATIENTS AND OFFER RAPID RESULTS 130
TABLE 61 ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES,
BY REGION, 2016–2019 (USD MILLION) 131
TABLE 62 ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES,
BY REGION, 2020–2026 (USD MILLION) 131
9.4 ACADEMIC RESEARCH INSTITUTES 131
9.4.1 GRANTS OFFERED BY ORGANIZATIONS TO SUPPORT THE GROWTH OF THIS SEGMENT 131
TABLE 63 ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES,
BY REGION, 2016–2019 (USD MILLION) 132
TABLE 64 ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES,
BY REGION, 2020–2026 (USD MILLION) 133
9.5 OTHER END USERS 133
TABLE 65 ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION,
2016–2019 (USD MILLION) 134
TABLE 66 ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION,
2020–2026 (USD MILLION) 134
10 ALLERGY DIAGNOSTICS MARKET, BY REGION 135
10.1 INTRODUCTION 136
TABLE 67 ALLERGY DIAGNOSTICS MARKET, BY REGION, 2016–2019 (USD MILLION) 136
TABLE 68 ALLERGY DIAGNOSTICS MARKET, BY REGION, 2020–2026 (USD MILLION) 136
10.2 NORTH AMERICA 137
FIGURE 29 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET SNAPSHOT 137
TABLE 69 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 138
TABLE 70 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 138
TABLE 71 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 138
TABLE 72 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2026 (USD MILLION) 139
TABLE 73 NORTH AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 139
TABLE 74 NORTH AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 139
TABLE 75 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 140
TABLE 76 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 140
TABLE 77 NORTH AMERICA: IN VIVO TESTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 140
TABLE 78 NORTH AMERICA: IN VIVO TESTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 141
TABLE 79 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 141
TABLE 80 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 141
TABLE 81 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 142
TABLE 82 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 142
10.2.1 US 142
10.2.1.1 The economic burden associated with allergies is expected to drive the growth of the market 142
TABLE 83 US: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 143
TABLE 84 US: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 143
TABLE 85 US: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 143
TABLE 86 US: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 144
TABLE 87 US: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 144
TABLE 88 US: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 144
TABLE 89 US: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 145
TABLE 90 US: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 145
TABLE 91 US: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 145
TABLE 92 US: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 146
TABLE 93 US: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 146
TABLE 94 US: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 146
10.2.2 CANADA 147
10.2.2.1 Rising funding activities in allergy diagnostics to drive the market growth in Canada 147
FIGURE 30 ALLERGIES, BY TYPE, POPULATION AGED 12 AND OLDER, CANADA (2017) 147
TABLE 95 CANADA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 148
TABLE 96 CANADA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 148
TABLE 97 CANADA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 148
TABLE 98 CANADA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 149
TABLE 99 CANADA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 149
TABLE 100 CANADA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 149
TABLE 101 CANADA: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 150
TABLE 102 CANADA: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 150
TABLE 103 CANADA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 150
TABLE 104 CANADA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 151
TABLE 105 CANADA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 151
TABLE 106 CANADA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 151
10.3 EUROPE 152
TABLE 107 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 152
TABLE 108 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY REGION,
2020–2026 (USD MILLION) 152
TABLE 109 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 153
TABLE 110 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 153
TABLE 111 EUROPE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 153
TABLE 112 EUROPE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 154
TABLE 113 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 154
TABLE 114 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 154
TABLE 115 EUROPE: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 155
TABLE 116 EUROPE: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 155
TABLE 117 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 155
TABLE 118 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 156
TABLE 119 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 156
TABLE 120 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 156
10.3.1 GERMANY 157
10.3.1.1 Germany accounted for the largest share of the EU market in 2020 157
TABLE 121 COMPARATIVE ANALYSIS OF ALLERGENS 157
TABLE 122 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 158
TABLE 123 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2026 (USD MILLION) 158
TABLE 124 GERMANY: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 158
TABLE 125 GERMANY: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 159
TABLE 126 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 159
TABLE 127 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 159
TABLE 128 GERMANY: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 160
TABLE 129 GERMANY: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 160
TABLE 130 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 160
TABLE 131 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 161
TABLE 132 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 161
TABLE 133 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 161
10.3.2 UK 162
10.3.2.1 Increasing prevalence of food anaphylaxis in the UK to support the market growth 162
TABLE 134 UK: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 163
TABLE 135 UK: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 163
TABLE 136 UK: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 163
TABLE 137 UK: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 164
TABLE 138 UK: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 164
TABLE 139 UK: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 164
TABLE 140 UK: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 165
TABLE 141 UK: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 165
TABLE 142 UK: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 165
TABLE 143 UK: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 166
TABLE 144 UK: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 166
TABLE 145 UK: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 166
10.3.3 FRANCE 167
10.3.3.1 Availability of reimbursements in France to support the growth of the market 167
TABLE 146 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 167
TABLE 147 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 167
TABLE 148 FRANCE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 168
TABLE 149 FRANCE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 168
TABLE 150 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 168
TABLE 151 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 169
TABLE 152 FRANCE: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 169
TABLE 153 FRANCE: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 169
TABLE 154 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 170
TABLE 155 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 170
TABLE 156 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 170
TABLE 157 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 171
10.3.4 ITALY 171
10.3.4.1 Presence of allergy diagnostic organizations in Italy to support allergy diagnosis research & demand for products 171
TABLE 158 ITALY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 171
TABLE 159 ITALY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 172
TABLE 160 ITALY: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 172
TABLE 161 ITALY: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 172
TABLE 162 ITALY: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 173
TABLE 163 ITALY: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 173
TABLE 164 ITALY: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 173
TABLE 165 ITALY: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 174
TABLE 166 ITALY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 174
TABLE 167 ITALY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 174
TABLE 168 ITALY: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 175
TABLE 169 ITALY: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 175
10.3.5 SPAIN 175
10.3.5.1 The government undertakes initiatives for the development of the healthcare system in Spain to support the market growth 175
TABLE 170 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 176
TABLE 171 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 176
TABLE 172 SPAIN: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 176
TABLE 173 SPAIN: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 177
TABLE 174 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 177
TABLE 175 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 177
TABLE 176 SPAIN: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 178
TABLE 177 SPAIN: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 178
TABLE 178 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 178
TABLE 179 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 179
TABLE 180 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 179
TABLE 181 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 179
10.3.6 REST OF EUROPE (ROE) 180
TABLE 182 ROE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 180
TABLE 183 ROE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 180
TABLE 184 ROE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 181
TABLE 185 ROE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 181
TABLE 186 ROE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 181
TABLE 187 ROE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 182
TABLE 188 ROE: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 182
TABLE 189 ROE: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 182
TABLE 190 ROE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 183
TABLE 191 ROE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 183
TABLE 192 ROE: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 183
TABLE 193 ROE: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 184
10.4 ASIA PACIFIC 184
FIGURE 31 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET SNAPSHOT 185
TABLE 194 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 186
TABLE 195 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY REGION,
2020–2026 (USD MILLION) 186
TABLE 196 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 186
TABLE 197 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2026 (USD MILLION) 187
TABLE 198 ASIA PACIFIC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 187
TABLE 199 ASIA PACIFIC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 187
TABLE 200 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 188
TABLE 201 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 188
TABLE 202 ASIA PACIFIC: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 188
TABLE 203 ASIA PACIFIC: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 189
TABLE 204 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 189
TABLE 205 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 189
TABLE 206 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 190
TABLE 207 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 190
10.4.1 CHINA 190
10.4.1.1 China accounted for the largest share of the allergy diagnostics market in the Asia Pacific 190
TABLE 208 CHINA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 191
TABLE 209 CHINA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 191
TABLE 210 CHINA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 192
TABLE 211 CHINA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 192
TABLE 212 CHINA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 192
TABLE 213 CHINA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 193
TABLE 214 CHINA: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 193
TABLE 215 CHINA: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 193
TABLE 216 CHINA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 194
TABLE 217 CHINA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 194
TABLE 218 CHINA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 194
TABLE 219 CHINA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 195
10.4.2 JAPAN 195
10.4.2.1 Increasing prevalence of allergies among children to propel the demand for allergy diagnostics in Japan 195
TABLE 220 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 196
TABLE 221 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 196
TABLE 222 JAPAN: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 196
TABLE 223 JAPAN: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 197
TABLE 224 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 197
TABLE 225 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 197
TABLE 226 JAPAN: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 198
TABLE 227 JAPAN: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 198
TABLE 228 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 198
TABLE 229 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 199
TABLE 230 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 199
TABLE 231 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 199
10.4.3 INDIA 200
10.4.3.1 Limited awareness regarding allergy management to limit the growth of the market 200
TABLE 232 INDIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 200
TABLE 233 INDIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 201
TABLE 234 INDIA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 201
TABLE 235 INDIA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 201
TABLE 236 INDIA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 202
TABLE 237 INDIA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 202
TABLE 238 INDIA: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 202
TABLE 239 INDIA: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 203
TABLE 240 INDIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 203
TABLE 241 INDIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 203
TABLE 242 INDIA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 204
TABLE 243 INDIA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 204
10.4.4 AUSTRALIA 204
10.4.4.1 High prevalence of food allergy to propel the growth of the allergy diagnostics market in Australia 204
TABLE 244 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 205
TABLE 245 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2026 (USD MILLION) 205
TABLE 246 AUSTRALIA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 206
TABLE 247 AUSTRALIA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 206
TABLE 248 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 206
TABLE 249 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 207
TABLE 250 AUSTRALIA: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 207
TABLE 251 AUSTRALIA: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 207
TABLE 252 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 208
TABLE 253 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 208
TABLE 254 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 208
TABLE 255 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 209
10.4.5 REST OF ASIA PACIFIC 209
TABLE 256 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 210
TABLE 257 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 210
TABLE 258 ROAPAC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 210
TABLE 259 ROAPAC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 211
TABLE 260 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 211
TABLE 261 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 211
TABLE 262 ROAPAC: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 212
TABLE 263 ROAPAC: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 212
TABLE 264 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 212
TABLE 265 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 213
TABLE 266 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 213
TABLE 267 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 213

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127